Safety and Efficacy Study of Bimatoprost in Japanese Patients With Eyelash Hypotrichosis

Study Identifier
192024-059
CT.gov Identifier
NCT01391273
EudraCT Identifier
Not available
EUCTIS ID
Not available
For general inquiries, please contact

844-663-3742 or [email protected]

Study Complete

Study Details

Medical Condition
  • Hypotrichosis
    • Study Drug
  • bimatoprost solution 0.03%
  • bimatoprost vehicle solution
    • Phase
    Phase 3
    Sex
    Female & Male
    Age
    20+ years
    Inclusion and Exclusion Criteria
    Inclusion Criteria:
    * Have inadequate eyelashes
    Exclusion Criteria:
    * Any disease/infection/abnormality of the eye or area around the eye * Any ocular surgery within 3 months or anticipated need for ocular surgery during the study * Any permanent eyeliner or implants of any kind or anticipated use of false eyelashes * Any semi-permanent eyelash tint, dye, curl or eyelash extension application within 3 months * Use of any over-the-counter eyelash growth product within 6 months or any use of prescription eyelash growth products * Use of treatments which may affect hair growth (eg, minoxidil, chemotherapy) within 6 months

    Protocol Summary

    This study will evaluate the safety and efficacy of bimatoprost solution 0.03% compared with vehicle in Japanese adults with hypotrichosis of the eyelashes.

    Study Locations

    Location
    Status
    Location
    Tokyo, Japan
    Status
    Not applicable